Marijuana and the Brain: From Addiction to Neuroscience

Slides:



Advertisements
Similar presentations
Stimulant dependence, compulsivity and dopamine TW Robbins CLARE HALL College for Advanced Study BCNI.
Advertisements

Brain Functions Treatment Options Paul Nims MA, CRADC, CCDP-D Co-Occurring Disorders Program Coordinator BJC Behavioral Health Marijuana.
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Marijuana and Teenage Psychosis David Ruffino Student Nurse. PPC Term Five.
Addiction and Dependency Jane Elphingstone, Ed.D Professor, Department of Health Sciences University of Central Arkansas.
Participants: 21 smokers (13M, ages 18-45) and 21 age-, gender-, race-, and education-matched controls. Procedure: Stimuli were 100 photographs: 50 food.
Mayfield Publishing Company Addictive Behaviors  Habits that have gotten out of control, with a resulting negative impact on health.
The Neurobiology of Addiction
Drug Addiction Part II Karen Revere Kian Eftekhari Will Hiesinger.
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
 It is when one is dependent on any kind of substance, illegal drug or a medication  You may not be able to control your drug use  It can cause an.
Cannabis Sativa Leaves, flowers, stems, and seeds are smoked, combined with food, or brewed as tea Marijuana – dried leaves and flowers Hashish – concentrated,
JESSICA KAHN, MD MPH Marijuana and the Teen Brain.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
Young people and the consequences of marijuana use Kevin Haggerty, Ph. D. Social Development Research Group, University.
C2004 Alcohol Medical Scholars Program1 Craving Karen Drexler, M.D. Emory University School of Medicine.
Chapter 18 Psychoactive Substance Use Disorders: Drugs.
Substance Use Disorders in Adolescence Chapter 15 Sandra A. Brown, Kristin Tomlinson, and Jennifer Winward.
Addiction A disease. Facts About Addiction & Treatment WHAT IS ADDICTION? A BRAIN DISEASE BUT WITH BIOLOGICAL, PSYCHOLOGICAL & SOCIAL COMPONENTS DOES.
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 17 Substance-Related Disorders – Focus on Alcoholism.
Terrence D. Walton, MSW, CSAC Pretrial Services Agency for the
Drugs and Consciousness Psychoactive Drug: A chemical substance that alters perceptions and mood (effects consciousness).
New Insights into Substance Use Disorders (SUD) From Brain Imaging Iliyan Ivanov. MD Mount Sinai School of Medicine Alcohol Medical Scholars Program 1.
THE IMPACT OF MARIJUANA ON HEALTH AND HEALTHCARE Ewald Horwath, MD, MS, FAPA Professor and Chair, Department of Psychiatry Associate Clinical Director,
Relation between alcohol abuse and impulsivity - Jayandra Chiluwal.
Announcements Truth, Lies & Addiction: Secrets of the Tobacco Industry by Dr. Victor DeNoble Wednesday, 10/ :00 Conoco Phillips Alumni Center Psychology.
Marijuana and Psychosis Prepared by Dr Amir Barsoum, MD, FRCPC Home on the Hill Lecture Series Sept 16, 2015.
Substance-Related Disorders and Addictive Disorders Levels of involvement –Substance use –Substance intoxication –Substance abuse –Substance dependence.
 The most commonly used illicit drug in the U.S.  95 million Americans, ages 12 or older have at least tried marijuana at some point.  ¾ illicit drug.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Endocannabinoid signaling and stress in CVS Thangam Venkatesan, MD Associate Professor of Medicine Division of Gastroenterology and Hepatology Medical.
The Neurobiology of Free Will In National Institute on Drug Abuse
Psychoactive Drugs A chemical substance that alters perceptions and moods.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Selected Effects on Brain, Body
Chapter 14 Opener State initiatives such as the 2012 Oregon Cannabis Tax Act are aimed at decriminalizing or even legalizing the possession and use of.
Drug abuse liability is associated with higher reward-sensitivity: An fMRI study using the Monetary Incentive Delay task C. Corbly, T. Kelly, Y. Jiang,
Cannabis and Schizophrenia. Major Constituents of Cannabis The two major substances found in cannabis include tetrahydrocannabinol (THC) and cannibidiol.
MARIJUANA. Most commonly used illegal drug Psychoactive Drug 6.8% of high school students admit to using marijuana in the last month 69 Million Americans.
COGNITIVE RAMIFICATIONS OF ADOLESCENT CANNABIS USE Randi Schuster, Ph.D. Massachusetts General Hospital Harvard Medical School © AMSP
Marijuana Gateway drug?? What does that mean?
screening, brief intervention and referral to treatment
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
screening, brief intervention & referral to treatment
Medical Cannabis Dr. Andrea Burry MSc MD CCFP
The Yin and Yang of Cannabis
Meghan E. Martz, PhD, Robert A. Zucker, PhD, Mary M. Heitzeg, PhD
Adolescents and Substance Abuse
Marijuana Unit [High School Name].  Learning Objective 1: Describe what marijuana is, and identify the psychoactive ingredient in cannabis.
Gaming disorder and ICD-11 beta
CANNABIS AND CANNABINOIDS: THE CONUNDRUM
1 Gene Environment Interaction THC THC THC COMT Pre-adolescence period
Substance abuse reveiw
EXPLORING PSYCHOLOGY EIGHTH EDITION IN MODULES David Myers
Todd Davis, MD, MMM EVP & CMO, CaroMont Health
Assessing Opioid Use Disorder, part 1
Drugs and Consciousness
Illegal Drug Use in the U.S.
Addiction and Dependency
Diagnosis and Recognition of OUD
Psychoactive Drugs Because the nervous system interacts with every other system of the body, dysfunction of any of its parts can have numerous effects.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Drug Use and Abuse PPL 10 Grade 9 ~ Mrs. Longval.
Joseph I. Friedman et al. JIMG 2014;7:
Gender Issues and Addiction
WHAT MEDICAL MARIJUANA DOCTORS HAVE TO SAY ABOUT THE ENDOCANNABINOID SYSTEM.
Neurological Aspects of THC as a Treatment for Generalized Anxiety
SUBSTANCE ABUSE.
Presentation transcript:

Marijuana and the Brain: From Addiction to Neuroscience Francesca Filbey, PhD Center for BrainHealth School of Behavioral and Brain Sciences University of Texas at Dallas President’s Dream Colloquium Simon Fraser University February 23, 2017

Oldest marijuana: 2,700 years old Journal of Experimental Botany, 2008

Marijuana is the most prevalent illicit drug In 2010, more than 29 million Americans (11.5%) aged 12 or older reported abusing marijuana within the past year. ~9-10% who use marijuana become dependent. PREVALENCE OF USE TREATMENT RATES SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2013.

Changing marijuana landscape

What do we know?

Cannabis has psychoactive ingredients ~483 chemical compounds 113 cannabinoids Tetrahydrocannabinol (THC) – CB1 receptors in central nervous system Cannabidiol (CBD) – indirect effects on CB1 and CB2 Cannabinol (CBN ) - CB2 receptors in peripheral organs (immune system)

The Endocannabinoid System (ECS) ECS regulates various physiological processes. higher order cognitive functions, pain, appetite, immune system response, mood, reward and motivation. Types of cannabinoids: Endocannabinoid – Brain-derived Anandamide (AEA), 2-Arachidonoylglycerol (2-AG) Phytocannabinoids – Plant-derived THC, CBD, CBN, etc. Synthetic cannabinoids – Laboratory-derived Marinol, K2 or Spice

Targeted Brain Areas

M A P Bloomfield et al. Nature 539, 369–377 (2016) doi:10 M A P Bloomfield et al. Nature 539, 369–377 (2016) doi:10.1038/nature20153

Short and Long-term Changes Curran et al., Nature Reviews Neuroscience 17, 293–306 (2016) doi:10.1038/nrn.2016.28

Neural changes in rat brain Journal of Neurochemistry Volume 73, Issue 6, pages 2447-2459, 18 JAN 2002 DOI: 10.1046/j.1471-4159.1999.0732447.x http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.1999.0732447.x/full#f2

Changes in human neuroanatomy Neuroanatomical alterations in cannabis users CB1R density Overlap between alterations and CB1R density Non-overlap between alterations and CB1R density Biological Psychiatry 2016 79, e17-e31DOI: (10.1016/j.biopsych.2015.11.013)

Studying Marijuana and the Brain

Marijuana users in these studies N males 57 33 Mean age 24.5 ± 8.6 29.3 ± 8.3 Mean use (days per week) 6.2 ± 3.8 6.9 ± 0.6 Mean use (occasions per day) 4.5 ± 11.3 3.1 ± 1.6 Mean duration in years of regular use 6.8 ± 8.4 9.8 ± 8.0 Non-users 27 80 N males 5 39 Mean age 30.32 ± 10.1 30.04 ± 7.4

Magnetic Resonance Imaging (MRI) Functional MRI (fMRI) Structural MRI (sMRI) Diffusion Tensor Imaging (DTI) Astolfi et al., (2004)

Smaller Hippocampal and Amygdala Volumes Schacht ,Filbey et al., Neuropsychopharmacology 2012

Smaller OFC volume in MJ users Filbey et al., PNAS (in press)

Orbitofrontal cortex is part of the Brain’s Reward System Dopamine

Magnetic Resonance Imaging (MRI) Structural MRI (sMRI) Diffusion Tensor Imaging (DTI)

Measure of white matter integrity Fractional isotropy (FA) High FA Low FA

Lower FA in MJ users Orbitofrontal cortex Forceps minor Filbey et al., PNAS (2014)

Conclusions Gray and white matter alterations in marijuana users, particularly in the orbitofrontal cortex

Magnetic Resonance Imaging (MRI) Functional MRI (fMRI) Structural MRI (sMRI) Diffusion Tensor Imaging (DTI) Astolfi et al., (2004)

Role of craving in addiction Diagnostic and Statistical Manual of Mental Disorders (DSM), published by the American Psychiatric Association Criterion DSM IV DSM 5 Failure to meet obligations Recurrent use Legal problems Social problems Tolerance Withdrawal Loss of control Unsuccessful quit attempts Time spent Give up activities Continued use despite harm Craving 1 = abuse 4-5 = moderate >6 = severe 2-3 = mild 3 = dependence

Cue exposure task in the MRI scanner Filbey et al., PNAS (2009)

Greater response to pipe Filbey et al., PNAS (2009)

Positive correlations Marijuana Problem Scale Age of onset High FA Filbey et al., PNAS (2009)

Conclusions Gray and white matter alterations in marijuana users, particularly in the orbitofrontal cortex Greater reward response to marijuana cues in marijuana users

Leif Parsons, NY Times

Cue exposure task: marijuana vs. natural reward OR

Response to MJ, food and neutral cues Pipe > Pencil Fruit > Pencil MJ > NU NU > MJ

Response to MJ, food and neutral cues Pipe > Fruit MJ NC MJ NU

Conclusions Gray and white matter alterations in marijuana users, particularly in the orbitofrontal cortex Greater reward response to marijuana cues in marijuana users Greater reward response to marijuana cues suggests incentive sensitization (vs. reward deficiency)

What about motivation?

Incentive motivation in the reward circuit N=14 healthy males Wrase et al, NeuroImage (2007)

Monetary Incentive Delay Task Knutson et al., NeuroImage(2000)

Positive and negative motivation MJ users Non-users Filbey et al., PLOS One (2013)

Conclusions Gray and white matter alterations in marijuana users, particularly in the orbitofrontal cortex Greater reward response to marijuana cues in marijuana users Greater reward response to marijuana cues suggests incentive sensitization (vs. reward deficiency) MJ users are sensitive to positive reinforcers, but not negative reinforcers

What about learning and memory?

Neural effort (EEG alpha and beta) Serial Reaction Time (SRT) Task

Conclusions Gray and white matter alterations in marijuana users, particularly in the orbitofrontal cortex Greater reward response to marijuana cues in marijuana users Greater reward response to marijuana cues suggests incentive sensitization (vs. reward deficiency) MJ users are sensitive to positive reinforcers, but not negative reinforcers MJ users exhibit impaired learning associated with low alertness .

Who are at risk?

Onset of use Individuals with a history of childhood abuse have been found to have earlier onsets of substance abuse (Dembo et al. 1988; Harrison et al. 1997; Widom et al. 1999).

Earlier onset = less activation in control areas ACG mid-FG

Early life stress Physical and sexual abuse during childhood is highly associated with MJ use in adulthood (hazard ratio =2.16) (Duncan et al., 2008). Prospective studies show that levels of stress in adolescents are predictive of greater severity of substance abuse (Kaplan et al. 1986; Newcomb and Bentler, 1988; Kaplan and Johnson 1992; Wills et al. 1996) monkeys with stress have less binding in dopamine D2 receptors in receptors  Morgan et al. Nat Neurosci. (2002)

Childhood adversities and substance use N=46, 12-17 year old non-using youth

Response to acute stress 4 x 10/5 = ? TIMEOUT! 1 2 3 4 5 6 7 8 9

Response during stress positively correlated with Marijuana Problem Scale

Genes regulate neurobiology Pet study (Hirvonen et al., 2011) 20% reduction of CB1 receptors in cannabis smokers compared to controls Amount of CB1 receptors correlated with duration of years

CNR1 is associated with differences in brain volume Schacht ,Filbey et al., Neuropsychopharmacology 2012

FAAH C + CNR1 G = greater response Striatum Orbitofrontal cortex (OFC) Activation Activation 1 2 1 2 Number of Risk Alleles Striatum OFC Filbey et al., Neuropsychopharmacology, 2010

Chicken or Egg? Conclusions Gray and white matter alterations in marijuana users, particularly in the orbitofrontal cortex Greater reward response to marijuana cues in marijuana users Greater reward response to marijuana cues suggests incentive sensitization (vs. reward deficiency) MJ users are sensitive to positive reinforcers, but not negative reinforcers MJ users exhibit impaired learning associated with low alertness Factors increase vulnerability to MJ’s effects: age of onset, stress, genetics Chicken or Egg?

Thank you! This research is supported by NIDA KO1 , NIDA RO1 Special thanks to all of the participants (NM, TX)! Joseph Dunlop, PhD Derek Beaton Herve Abdi, PhD Sina Aslan, PhD Sam DeWitt Ariel Ketcherside Shikha Prashad, PhD Filbey lab Sherwood Brown, MD Bryon Adinoff, MD Sarah Feldstein Ewing, PhD Ursula Myers Kent Hutchison, PhD Vince Calhoun, PhD Joseph Schacht, PhD Mike Doty, MS www.filbeylab.com